Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


Two US pharmas target Aust

Posted 15 September 2020

Three new drugs made their first appearance in Australia as Merck Healthcare and two US companies received orphan drug designations through the TGA this month.

This includes Merck's precision medicine tepotinib, discovered in-house for the treatment of non-small cell lung cancer (NSCLC) with genetic MET alterations.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Special Report
Aust Covid Vaccine Tracker
Live updates on frontrunners, local trials and deals
Approvals Action
Six pharmas add generics
Most copy PBS listed drugs
Top of the Hill
If only for a 2020 time machine
What would you do if you could start this year again?